TOKYO and LONDON, May 14, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"); (TSE: 4565) reports encouraging progress and initial success of its strategic multi-target drug discovery collaboration with Pfizer.
Growth Capitalist (https://growthcapitalist.com/2019/05/sosei-heptares-reports-progress-with-pfizer-as-multi-target-collaboration-delivers-first-candidate-for-clinical-advancement/)
TOKYO and LONDON, May 14, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"); (TSE: 4565) reports encouraging progress and initial success of its strategic multi-target drug discovery collaboration with Pfizer.